[MY 25, a peroral prophylactic for migraine].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D004485:Eczema / Q000139:chemically induced; D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010919:Placebos; D011537:Pruritus / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced
D010919:Placebos; D004878:Ergotamine
MY 25, et peroralt, profylaktisk migraenemiddel.